Multidisciplinary context of research of a new drug in infectious and inflammatory diseases

Valentyn Shapovalov; Viktoriia Shapovalova; Alina Osyntseva; Valerii Shapovalov; Oleksandr Veits; Yurii Titarenko

doi:10.5281/zenodo.13820208

Authors

Valentyn Shapovalov Private Scientific Institution “Scientific and Research University of Medical and Pharmaceutical Law”, Ukraine https://orcid.org/0000-0002-9329-0195
Viktoriia Shapovalova Lviv Medical University, Ukraine https://orcid.org/0000-0003-4770-7292
Alina Osyntseva Lviv Medical University, Ukraine https://orcid.org/0000-0003-1655-318X
Valerii Shapovalov Lviv Medical University, Ukraine https://orcid.org/0000-0002-6696-6380
Oleksandr Veits Private Scientific Institution “Scientific and Research University of Medical and Pharmaceutical Law”, Ukraine https://orcid.org/0000-0003-3798-3816
Yurii Titarenko Private Scientific Institution “Scientific and Research University of Medical and Pharmaceutical Law”, Ukraine https://orcid.org/0009-0002-8664-9013

DOI:

https://doi.org/10.5281/zenodo.13820208

Keywords:

paracetamol, ascorbic acid, analysis, application

Abstract

Introduction. The multidisciplinary context of the study of a new drug for infectious-inflammatory diseases based on the combination of evidence-selected pharmacological substances paracetamol and ascorbic acid was developed. Competences of the organization of pharmacy, medicine, pharmacology, forensic pharmacy, pharmaceutical analysis, and social medicine were used. The aim: Noted that the raw material base, production in the conditions of pharmacies and pharmaceutical enterprises of paracetamol + ascorbic acid tablets is economically expedient, socially oriented in the conditions of a military conflict. Materials and methods. Quality control methods have been developed: determination of para-aminophenol, paracetamol, and ascorbic acid. The results of organizational, documentary, pharmacological, medical, pharmaceutical, physicochemical, and social studies were used. According to physical and chemical studies, the determination of para-aminophenol by spectrophotometric method is proposed. It was determined that experimental samples of the drug do not contain impurities of free para-aminophenol. The maximum permissible content of para-aminophenol in tablets of the drug under study is no more than 0.1%. Results. The complex of developed methods and standardization of quality control indicators of paracetamol + ascorbic acid tablets meet the requirements of the latest pharmacopoeias. The methods of quantitative determination of the active substances of the drug used in the development of analytical and control documentation, the system of quality control of the drug in further production in the conditions of pharmacies or pharmaceutical enterprises. Conclusions. The main areas of application of paracetamol + ascorbic acid tablets are indicated: infectious diseases with an increase in temperature; pain syndromes of weak and medium intensity of various genesis. Appeared promising to include the new drug in the pharmacotherapy schemes of health care institutions. The social context of the study is relevant in emergency situations, in the conditions of a military conflict, to reduce the suffering of victims of pain, inflammation, fever, and improve the quality of life of patient

Keywords: paracetamol ascorbic acid analysis application

References

Shapovalova, V. (2022). Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine, 2(4), 1–24. https://doi.org/10.53933/sspmpm.v2i4.69.

Shapovalova, V. (2023). Pharmacotherapy of Depressive disorders in conditions of coronavirus disease: pharmacoeconomic experimental study. SSP Modern Pharmacy and Medicine, 3(3), 1-11. https://doi.org/10.53933/sspmpm.v3i3.101

Shapovalova, V. (2023). Interdisciplinary pharmacoeconomic research concerning the pharmacotherapy of Аlcoholic Hepatitis in conditions of COVID-19 pandemic. SSP Modern Pharmacy and Medicine, 3(2), 1-10. https://doi.org/10.53933/sspmpm.v3i2.87

Shapovalova, V. (2022). An Innovative multidisciplinary study of the availability of coronavirus vaccines in the world. SSP Modern Pharmacy and Medicine, 2(2), 1–17. https://doi.org/10.53933/sspmpm.v2i2.45

COVID pandemic fuelling major increase in drug use worldwide: UN report. United Nations. 24.06.2021. https://news.un.org/en/story/2021/06/1094672

Fazio, S., Cosentino, M., Marino, F., Pandolfi, S., Zanolin, E., Bellavite, P. (2022). The Problem of home therapy during COVID-19 pandemic in Italy: government guidelines versus freedom of cure? Fortunejournals. Journal of Pharmacy and Pharmacology Research, 6, 100-122. https://www.fortunejournals.com/articles/the-problem-of-home-therapy-during-covid19-pandemic-in-italy-government-guidelines-versus-freedom-of-cure.html

Li, G.-D. ( 2022). Taking Paracetamol and Vitamin C or Ibuprofen and Vitamin C every day could be a simple way to prevent COVID-19 infection. Open Access Library Journal, 9(12), 1-5. https://www.scirp.org/journal/paperinformation.aspx?paperid=121925

Faziо, S., Affusо F., Bellavite, P. A. (2022). Review of the potential roles of antioxidant and anti-Inflammatory pharmacological approaches for the management of mild-to-moderate symptomatic COVID-19. MSM, 28: e936292. https://medscimonit.com/abstract/full/idArt/936292

Hemilä, H., M. E. de Man, A. (2021). Vitamin C and COVID-19. Front Med (Lausanne), 18(7), 559811. https://pubmed.ncbi.nlm.nih.gov/33537320/

Shapovalov, V. (Jr.), Gudzenko, A., Shapovalova, V., Komar, L., Butko, A., Shapovalov, V. (2017). Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia, 65(2), 23-29. http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.

Shapovalova, V.O., Mykhailov, V.S., Shapovalov, V.V. (1999). The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice. Fiziolohichnyi zhurnal, 45(3), 114–117. https://pubmed.ncbi.nlm.nih.gov/10439301/

Shapovalova, V.A., Shapovalov, V.V. (1999). The clinical efficacy of the combined drug agent Valcophen in children. Likars'ka sprava, 1, 124–126. https://pubmed.ncbi.nlm.nih.gov/10424023/

International harmonisation. Council of Europe. (2021). https://www.edqm.eu/en/international-harmonisation

European pharmacopoeia: Quality standards for medicines. EUPATI. https://toolbox.eupati.eu/resources/european-pharmacopoeia-quality-standards-for-medicines/

USP 43-NF 38. (2019). USP-NF. https://www.uspnf.com/notices/usp-nf-final-print-edition.

European Pharmacopoeia. 10th Edition. Council of Europe. (2021). https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition/.

British Pharmacopoeia. Pharmacopoeia. (2020). https://www.pharmacopoeia.com/downloads/bp/2020/.

State Pharmacopoeia of Ukraine. Second Edition. Supplement 7. (2024). Vol.1 (296 p.); Vol.2 (424 p.). https://srumpl.org/ena/SPU.html

Gryzodub, O., Shapovalov, V. (2023). Quality Systems in Pharmacy: Multidisciplinary Context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice, 3(1), 1-23. https://doi.org/10.53933/sspmlp.v3i1.81

USP-NF. (2023). Iss.1. 1683p. https://www.uspnf.com/purchase-usp-nf?gclid=CjwKCAjwivemBhBhEiwAJxNWNwTdRWJLZwZ2DRrfqUxdwnTioR81dH9-XZ6F03keTKxocCs6tXmo3xoCCmkQAvD_BwE

Pietrusiewicz, M., Kopa-Stojak, P. N., Pawliczak, R. (2021). Pharmacist’s recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland. BMC Family Practice, 22, 216. https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-021-01561-2#citeas. https://doi.org/10.1186/s12875-021-01561-2

Mallet, C., Desmeules, J., Pegahi, R., Eschalier, A. (2023). An Updated review on the metabolite (AM404)-mediated central mechanism of action of Paracetamol (Acetaminophen): experimental evidence and potential clinical impact. Journal of Pain Research, 16,1081-1094. https://www.dovepress.com/an-updated-review-on-the-metabolite-am404-mediated-central-mechanism-o-peer-reviewed-fulltext-article-JPR

Anitta S., Sekar C. (2023). Voltammetric determination of paracetamol and ciprofloxacin in the presence of vitamin C using cuttlefish bone-derived hydroxyapatite sub-microparticles as electrode material. Results in Chemistry, 5, 100816. https://www.sciencedirect.com/science/article/pii/S2211715623000553

Shalaby, A.S., Eid, H.H., El-Shiekh, R.A., Osama, G., Ashootosh, T. et al. (2023). Taming food–drug interaction risk: potential inhibitory effects of citrus juices on cytochrome liver enzymes can safeguard the liver from overdose paracetamol-induced hepatotoxicity. ACS Omega, 8(9), 26444-26457. https://pubs.acs.org/doi/10.1021/acsomega.3c03100

Abdulrazzaq, A.M., Badr, M., Gammoh, O. et al. (2019). Silymarin or their combination against acetaminophen-induced hepatotoxicity in rats. Medicina, 55(5), 181. https://www.mdpi.com/1648-9144/55/5/181

Multidisciplinary context of research of a new drug in infectious and inflammatory diseases

Authors

DOI:

Keywords:

Abstract

References

Downloads

Published

How to Cite

Issue

Section

License

Current Issue

Language

Make a Submission